Skip to main content

Table 3 Overall antibiotic use

From: Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome

 Days of therapy/100 neutropenic days
Period IPeriod II
Therapeutical agentsCarbapenems40.331.6
Vancomycin26.712.1
Ceftazidime0.10.3
Ceftriaxone0.80.8
Piperacillin/tazobactam0.21.1
Penicillin3.13.8
Aminoglycosides0.50.6
Prophylactic agentsClindamycin10.97.0
Ciprofloxacin65.860.1
Cotrimoxazole *3.15.6
Cefazolin4.115.0
Total 155.6138.0
  1. *dose > 960 mg BID